We also divided patients as control into three clinical groups with different cirrhosis stages, hepatitis without cirrhosis, compensated cirrhosis and decompensated cirrhosis, to evaluate the effect of cirrhosis stage on baseline serum LAMP-2. The gene discussed is LAMP2; the disease is hepatitis A virus infection.